Umraniye Training and Research Hospital
Istanbul, 34764, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07439575
This prospective randomized clinical study aims to evaluate the effects of different suture materials and wound closure techniques on wound healing, functional outcomes, and postoperative complications in patients undergoing total hip and knee arthroplasty.
A total of at least 90 adult patients undergoing primary or aseptic revision lower extremity arthroplasty will be randomized into two groups according to the wound closure material and technique used. All surgeries will be performed by the same surgical team following standardized operative protocols.
Primary outcomes include wound-related complications such as prolonged wound drainage, wound dehiscence, surgical site infection, and local inflammatory findings within 90 days postoperatively. Secondary outcomes include operative time, bleeding amount, cosmetic outcomes, and functional scores.
The results of this study are expected to help determine the most effective and safe wound closure method in lower extremity arthroplasty.
Interested in participating?
Request Info30 year and older
All sexes
Interventional
Not applicable
Istanbul, 34764, Turkey (Türkiye)
Location status: Recruiting
Total hip and knee arthroplasty are commonly performed surgical procedures in the management of end-stage degenerative joint diseases. Optimal wound closure is critical in reducing postoperative complications such as prolonged wound drainage, wound dehiscence, surgical site infection, and delayed wound healing. Various suture materials and closure techniques are routinely used in clinical practice; however, consensus regarding the most effective method remains limited.
This prospective randomized study is designed to compare different suture materials and wound closure techniques in patients undergoing primary or aseptic revision total hip and knee arthroplasty. Participants will be randomly assigned in a 1:1 ratio to one of two wound closure strategies differing in both suture material and closure technique following total hip or knee arthroplasty. The study aims to determine their effects on wound healing, functional outcomes, and postoperative complications.
A minimum of 90 adult patients will be enrolled. Eligible patients will be randomized into two groups according to the wound closure material and technique used. All surgical procedures will be performed by the same surgical team following standardized perioperative protocols in order to minimize confounding variables.
Preoperative demographic data will be recorded. Intraoperative variables including operative time and intraoperative blood loss will be documented. Postoperative assessments will include wound drainage duration, signs of local inflammation, wound dehiscence, surgical site infection, bleeding complications, and cosmetic evaluation. Functional outcomes will be assessed using validated hip and knee scoring systems where applicable.
Patients will be followed for 90 days postoperatively. All data will be recorded in a secure database and analyzed using appropriate statistical methods. Continuous variables will be assessed for normal distribution and analyzed using parametric or non-parametric tests as appropriate. Categorical variables will be analyzed using Chi-square or Fisher's exact test. Multivariate logistic regression analysis will be performed to identify independent predictors of wound-related complications. A p-value < 0.05 will be considered statistically significant.
The findings of this study are expected to contribute to the optimization of wound closure strategies in lower extremity arthroplasty and improve postoperative outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wound closure using barbed suture material with continuous technique following total hip or knee arthroplasty.
Wound closure using conventional suture material with interrupted or standard closure technique following total hip or knee arthroplasty.
Time frame: Within 90 days after surgery
Wound-related complications include prolonged wound drainage, wound dehiscence, surgical site infection, and local inflammatory findings occurring within 90 days following total hip or knee arthroplasty.
Time frame: Intraoperative (Day of surgery)
Duration of surgery measured in minutes from skin incision to wound closure.
Time frame: Intraoperative (Day of surgery)
Estimated blood loss measured in milliliters during surgery.
Time frame: Within 90 days after surgery
Number of days with visible wound drainage after surgery.
Time frame: Within 90 days after surgery
Incidence of superficial or deep surgical site infection diagnosed according to clinical criteria within 90 days postoperatively.
Time frame: Within 90 days after surgery
Incidence of partial or complete wound separation within 90 days postoperatively.
Time frame: Preoperatively and at 3 months postoperatively
Functional outcomes will be assessed using the Harris Hip Score (HHS) (range 0-100, with 100 indicating best possible function; higher scores indicate better clinical outcomes) for patients undergoing total hip arthroplasty, and the Knee Society Score (KSS) (range 0-100, with 100 indicating best possible function; higher scores indicate better clinical outcomes) for patients undergoing total knee arthroplasty.
Contact information is provided by the study sponsor or research team.
Bahattin Kemah
Other Gov
Evaluation of Different Suture Materials and Closure Techniques in Lower Extremity Arthroplasty: Effects on Wound Healing, Functional Outcomes, and Complications
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06145516
Arthritis, Dyssomnias
Uppsala, Uppland, Sweden
View Trial DetailsNCT05761015
Arthritis, Chronic Pain
Clermont-Ferrand, France
View Trial DetailsNCT03711773
Arthralgia, Arthritis
Columbia, Missouri, United States
View Trial DetailsNCT05700682
Arthritis, Chronic Pain
Palo Alto, California, United States
View Trial Details